Literature DB >> 83237

H-2-linked murine cytotoxic T cell responses specific for sendai virus-infected cells.

R Kurrle, M Röllinghoff, H Wagner.   

Abstract

CBA (H-2k) mouse-derived lymphochoriomeningitis virus and herpes simplex virus-specific cytotoxic T lymphocytes lyse virus-infected target cells compatible on either the H-2k or H-2D region. In contrast, CBA, C3H and AKR (H-2k) mouse-derived sendai virus-specific cytotoxic T lymphocytes (CTL) fail to lyse H-2D-compatible virus-infected cells. A similar lack of H-2D region-associated lytic activity was found with C57BL/6 and C57BL/10 (H-2b) mice as well as with the recombinants B10.A (2R) [Kb-Db] and B10.A (4R) [Kk-Db]. On the other hand, BALB/c (H-2d) mice and A/J (H-2a) mice do generate H-2Dd-associated sendai virus-specific CTL. These results are in contrast to those obtained with (CBA X BALB/c)F1 and B10.HTT [Ks-Dd] mice, which failed to mount Dd region-associated CTL responses. It is concluded that D region-associated sendai virus-specific CTL responsiveness varies with the H-2 genotype of the responder cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 83237     DOI: 10.1002/eji.1830081216

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Anti H-2Dd alloreactivity mediated by herpes-simplex-virus specific cytotoxic H-2k T lymphocytes is associated with H-2Dk.

Authors:  K Pfizenmaier; H Jung; R Kurrle; M Röllinghoff; H Wagner
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

2.  Alternative splicing in the mouse H-2Kd gene is not necessary for the classical Kd antigen function.

Authors:  M Cochet; W M Kast; A M Kummer; C Transy; C J Melief; P Kourilsky
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

3.  Complement-dependent antiviral monospecific antibody-mediated lysis of murine cells coated with Sendai virus or its envelope component.

Authors:  Y Hosaka; Y Fukami; Y Yasuda; J A Bonilla
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

4.  Virus specificity of cytotoxic T lymphocytes generated during acute lymphocytic choriomeningitis virus infection: role of the H-2 region in determining cross-reactivity for different lymphocytic choriomeningitis virus strains.

Authors:  R Ahmed; J A Byrne; M B Oldstone
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

5.  Anti-influenza virus cytotoxic T lymphocytes recognize the three viral polymerases and a nonstructural protein: responsiveness to individual viral antigens is major histocompatibility complex controlled.

Authors:  J R Bennink; J W Yewdell; G L Smith; B Moss
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

6.  Cell-mediated immunity induced in mice after vaccination with a protease activation mutant, TR-2, of Sendai virus.

Authors:  M Tashiro; Y Fujii; K Nakamura; M Homma
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

7.  Distinct Ir genes for helper and killer cells in the cytotoxic response to H-Y antigen.

Authors:  H von Boehmer; W Haas
Journal:  J Exp Med       Date:  1979-11-01       Impact factor: 14.307

8.  Influence of the major histocompatibility complex on the repertoire of allospecific cytolytic T lymphocytes.

Authors:  L A Sherman
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307

9.  Three spontaneous H-2Db mutants are generated by genetic micro-recombination (gene conversion) events. Impact on the H-2-restricted immune responsiveness.

Authors:  S Hemmi; J Geliebter; R A Zeff; R W Melvold; S G Nathenson
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

10.  Frequency analysis of cytotoxic T lymphocyte precursors in chimeric mice. Evidence for intrathymic maturation of clonally distinct self-major histocompatibility complex- and allo-major histocompatiblilty complex-restricted virus-specific T cells.

Authors:  H Wagner; C Hardt; R Bartlett; H Stockinger; M Röllinghoff; H Rodt; K Pfizenmaier
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.